Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Gossamer Bio

Gossamer Bio Q1 Earnings Call Highlights

Gossamer Bio (NASDAQ:GOSS) said it is moving ahead with plans to seek U.S. approval for seralutinib in pulmonary arterial hypertension, outlining a September 2026 target for a New Drug Application submission while also detailing new imaging data and steps to address its balance sheet during its firs

3 Biotech Stocks That Could More Than Triple if Their Trials Succeed

3 Biotech Stocks That Could More Than Triple if Their Trials Succeed

While the risks remain significant with biotech stocks, the potential rewards could be equally compelling.

Benzinga's Top Ratings Upgrades, Downgrades For September 21, 2022

Benzinga's Top Ratings Upgrades, Downgrades For September 21, 2022

Upgrades For Berkshire Hathaway Inc (NYSE:BRK), Edward Jones upgraded the previous rating of Hold to Buy. Berkshire Hathaway earned $6312.49 in the second quarter, compared to $4399.91 in the year-ago quarter.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

12 Health Care Stocks Moving In Wednesday's Intraday Session

Where Gossamer Bio Stands With Analysts

Analysts have provided the following ratings for Gossamer Bio (NASDAQ:GOSS) within the last quarter:

Benzinga's Top Ratings Upgrades, Downgrades For April 18, 2022

Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2022

inkl

Read news from The Economist, FT, and more,
with one subscription

Recap: Gossamer Bio Q4 Earnings

Recap: Gossamer Bio Q4 Earnings

Gossamer Bio (NASDAQ:GOSS) reported its Q4 earnings results on Thursday, March 3, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings Gossamer Bio reported in-line EPS of $-0.74 versus an estimate of $-0.74.

Gossamer Bio Earnings Preview

Gossamer Bio Earnings Preview

Gossamer Bio (NASDAQ:GOSS) is set to give its latest quarterly earnings report on Thursday, 2022-03-03. Here's what investors need to know before the announcement. Analysts estimate that Gossamer Bio will report an earnings per share (EPS) of $-0.74.

1

Organisations

Berkshire Hathaway

Delta Air Lines

Western Digital

Micron Technology

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play